FPH.AX - Fisher & Paykel Healthcare Corporation Limited

ASX - ASX Delayed price. Currency in AUD
+0.15 (+1.26%)
At close: 4:10PM AEDT
Stock chart is not supported by your current browser
Previous close11.92
Bid11.85 x 0
Ask12.22 x 0
Day's range11.93 - 12.20
52-week range8.67 - 13.10
Avg. volume371,790
Market cap6.913B
PE ratio (TTM)55.11
EPS (TTM)0.22
Earnings dateN/A
Forward dividend & yield0.16 (1.33%)
Ex-dividend dateN/A
1y target est9.19
  • 4 quality mid-caps I’d consider buying today
    Motley Fool8 days ago

    4 quality mid-caps I’d consider buying today

    High return on equity, low debt, and good cash flow are indicators of a good quality business. Four mid-caps that have produced great numbers in these areas are A2 Milk Company Ltd (ASX:A2M), Altium Limited (ASX:ALU), Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) and Bellamy’s Australia Limited (ASX:BAL).

  • AAP4 months ago

    Fisher & Paykel wins patent court case

    Fisher & Paykel Healthcare has won a patent case against rival medical products manufacturer ResMed, after a court in the United Kingdom ruled the patent claim invalid. In 2016, New Zealand-based Fisher & Paykel sought a declaration from the High Court that three of ResMed's European patents were invalid in the UK and should be revoked. ResMed revoked two of its patents in the UK just before the trial was due to start, but left one for consideration by the High Court's patents division.

  • We're sorry this is all we were able to find about this topic.